Elequin Capital LP Amphastar Pharmaceuticals, Inc. Transaction History
Elequin Capital LP
- $825 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$166 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$75.6 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$51.3 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$44.5 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$38.3 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.37B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...